Big Gain For Vir Biotechnology, Inc.
Wed, Jan 08, 2025 at 07:09 PM
Vir Biotechnology, Inc. (VIR:NASDAQ) shot up at $12.48, a gain of 58.2%. On Wed, Jan 08, 2025, VIR:NASDAQ touched a New 2-Week High of $12.48. The stock appeared on our News Catalysts scanner on Wed, Jan 08, 2025 at 10:30 AM in the 'BIOTECH' category. From Thu, Dec 26, 2024, the stock recorded 62.50% Up Days and 44.44% Green Days
About Vir Biotechnology, Inc. (VIR:NASDAQ)
Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions.
Top 10 Gainers:
- Sana Biotechnology, Inc. (SANA:NASDAQ), 160.61%
- Accolade Inc. (ACCD:NASDAQ), 104.78%
- Trio Petroleum Corp. (TPET:NYSEMKT), 60.63%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 58.17%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- 22nd Century Group Inc (XXII:NASDAQ), 40.87%
- AngioDynamics, Inc. (ANGO:NASDAQ), 37.66%
- N2OFF Inc. (NITO:NASDAQ), 34.31%
- EON Resources Inc Com (EONR:NYSEMKT), 33.42%
- Crown LNG Holdings Limited (CGBS:NASDAQ), 26.44%